En esta página
01OVID precio
02Instantánea
03Gráfico
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
23Noticias
26Mis Métricas
OVID Ovid Therapeutics Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 13, 2026
$2,38
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$1,18mínimo 52 semanas
$3,11máximo 52 semanas
Capitalización Bursátil (MRQ)
$440M
P/E
-7.5
BPA
$-0.74
Ingresos
$7M
tus insignias
Rango 52S
$1–$3
Calificación del Analista
BUY
Precio Objetivo
$6
P/E
-7.5
ROE
-18.7%
Margen de Beneficio Neto
-2178.9%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
OVID Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$2.38
Capitalización Bursátil (MRQ)
$440M
P/E
-7.5
BPA
$-0.74
Ingresos
$7M
ROE
-18.7%
Rango 52S
$1–$3
OVID Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$7M2020-12-31 → 2025-12-31
BPA$-0.742020-12-31 → 2023-12-31
Flujo de caja libre$-38M2017-12-31 → 2025-12-31
Margen neto-2178.9%2020-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | OVID | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -7.5promedio 5A ≈-2.2 | ≈-2.2 | · | · | |
| P/S (TTM) | 277.8promedio 5A ≈174.6 | ≈174.6 | 3.7 | Sobrevalorado | |
| P/C (MRQ) | 2.1promedio 5A ≈1.6 | ≈1.6 | 3.0 | Infravalorado | |
| Price / FCF (Precio / FCF) | -10.4promedio 5A ≈-2.7 | ≈-2.7 | · | · | |
| Price / Cash Flow (Precio / Flujo de Caja) | -10.4promedio 5A ≈-2.7 | ≈-2.7 | · | · | |
| Precio / Valor Contable Tangible (MRQ) | 2.1promedio 5A ≈1.5 | ≈1.5 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | OVID | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -3686.7%promedio 5A ≈-4839.2% | ≈-4839.2% | -47.4% | Débil | |
| Margen EBITDA (TTM) | -3681.4%promedio 5A ≈-4793.4% | ≈-4793.4% | -47.4% | Débil | |
| Margen antes de impuestos (TTM) | -2178.9%promedio 5A ≈-4286.8% | ≈-4286.8% | -61.1% | Débil | |
| Margen de Beneficio Neto (TTM) | -2178.9%promedio 5A ≈-4287.0% | ≈-4287.0% | -28.8% | Débil | |
| ROA | -14.3%promedio 5A ≈2.6% | ≈2.6% | -14.3% | En línea | |
| ROE | -18.7%promedio 5A ≈-12.1% | ≈-12.1% | -14.4% | Débil | |
| ROIC | -32.5%promedio 5A ≈-18.4% | ≈-18.4% | -12.1% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | OVID | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 12.4promedio 5A ≈12.5 | ≈12.5 | 10.4 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 1.6promedio 5A ≈5.8 | ≈5.8 | 2.9 | Baja liquidez |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | OVID | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 1181.3%promedio 5A ≈520.8% | ≈520.8% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 69.0%promedio 5A ≈-28.5% | ≈-28.5% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | -10.5% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | OVID | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.1promedio 5A ≈0.4 | ≈0.4 | 0.4 | Débil | |
| Revenue / Employee (Ingresos / Empleado) | ≈$315.3K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
37.4%
Próximo informe
Nov 10, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 18, 2026 | $-0.08 | $-0.12 | 35.2% |
| 31 de marzo de 2026 | May 13, 2026 | $-0.12 | $-0.12 | 2.2% |
| 31 de diciembre de 2025 | $0.06 | $-0.12 | 149.4% | |
| 30 de septiembre de 2025 | $-0.17 | $-0.15 | -11.2% | |
| 30 de junio de 2025 | $-0.06 | $-0.16 | 63.6% | |
| 31 de marzo de 2025 | $-0.14 | $-0.14 | -0.43% | |
| 31 de diciembre de 2024 | $-0.13 | $-0.17 | 23.2% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $7M | $566.0K | $392.0K | $2M | $208M | $13M | |
| R&D Expense | $26M | $37M | $29M | $25M | $47M | $63M | |
| SG&A Expense | $24M | $26M | $31M | $32M | $37M | $31M | |
| Operating Expenses | $50M | $62M | $60M | $57M | $84M | $94M | |
| Operating Income | $-42M | $-62M | $-59M | $-56M | $124M | $-81M | |
| Interest Income | $2M | $4M | $5M | · | · | · | |
| Other Non-op | $25M | $35M | $7M | $1M | $-45.7K | · | |
| Pretax Income | $-17M | $-26M | $-52M | $-54M | $124M | $-81M | |
| Income Tax | $0 | $0 | $0 | $0 | $1M | $0 | |
| Net Income | $-17M | $-26M | $-52M | $-54M | $123M | $-81M | |
| EPS (Basic) | · | · | $-0.74 | $-0.77 | $1.78 | $-1.39 | |
| EPS (Diluted) | · | · | $-0.74 | $-0.77 | $1.76 | $-1.39 | |
| Shares (Basic) | · | · | 70,580,604 | 70,424,819 | 67,479,403 | 58,451,293 | |
| Shares (Diluted) | · | · | 70,580,604 | 70,424,819 | 68,067,992 | 58,451,293 | |
| EBITDA | $-42M | · | $-59M | $-55M | $124M | $-81M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $26M | $27M | $45M | $188M | $72M | |
| Prepaid Expense | $5M | $3M | $4M | $2M | $3M | $3M | |
| Current Assets | $74M | $56M | $110M | $131M | $190M | $75M | |
| PP&E (Net) | $252.0K | $433.0K | $769.0K | $1M | $242.8K | $135.6K | |
| Accum. Depreciation | $2M | $1M | $1M | $581.4K | $262.2K | $185.3K | |
| Intangibles | $0 | $100.0K | $200.0K | $222.1K | $164.1K | $319.0K | |
| Other Non-current Assets | $0 | $92.0K | $210.0K | $261.2K | $260.1K | $318.9K | |
| Total Assets | $151M | $92M | $144M | $155M | $195M | $76M | |
| Accounts Payable | $2M | $3M | $4M | $2M | $7M | $5M | |
| Accrued Liabilities | $5M | $6M | $7M | $5M | $8M | $12M | |
| Current Liabilities | $8M | $11M | $11M | $7M | $15M | $22M | |
| Capital Leases | $12M | $13M | $15M | $16M | $0 | · | |
| Total Liabilities | $20M | $24M | $56M | $23M | $15M | $32M | |
| Common Stock | $130.0K | $71.0K | $71.0K | $70.5K | $70.4K | $65.7K | |
| Paid-in Capital | $452M | $372M | $366M | $358M | $351M | · | |
| Retained Earnings | $-322M | $-304M | $-278M | $-226M | $-171M | $-294M | |
| AOCI | $-202.0K | $-35.0K | $1.0K | $-42.2K | $0 | · | |
| Stockholders' Equity | $131M | $68M | $88M | $132M | $180M | $44M | |
| Liabilities + Equity | $151M | $92M | $144M | $155M | $195M | $76M | |
| Shares Outstanding | 130,184,353 | 71,009,866 | 70,691,992 | 70,466,885 | 70,364,912 | 65,743,170 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $273.0K | $613.0K | $568.0K | $512.5K | $237.1K | $306.8K | |
| Stock-based Comp | $5M | $6M | $7M | $7M | $5M | $8M | |
| Deferred Tax | · | · | · | · | · | $6M | |
| Amort. of Intangibles | $100.0K | $200.0K | $100.0K | $193.3K | $160.2K | $247.0K | |
| Other Non-cash | $-26M | · | $-1M | $-8M | $-10M | $16M | |
| Operating Cash Flow | $-38M | $-56M | $-46M | $-55M | $119M | $-52M | |
| CapEx | $0 | $71.0K | $40.0K | $1M | $184.0K | $127.2K | |
| Investing Cash Flow | $-50M | $55M | $-3M | $-88M | $-2M | $35M | |
| Stock Issued | · | · | · | · | $0 | $47M | |
| Net Stock Activity | · | · | · | · | $0 | · | |
| Financing Cash Flow | $75M | $622.0K | $31M | $180.7K | $904.1K | $47M | |
| Net Change in Cash | $-13M | $-740.0K | · | $-143M | $118M | $30M | |
| Free Cash Flow | $-38M | · | $-46M | $-56M | $118M | $-52M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -585.2% | · | -15134.6% | -3696.4% | 59.6% | -645.4% | |
| Net Margin | -240.1% | · | -13362.2% | -3604.7% | 59.0% | -642.3% | |
| Pretax Margin | -240.1% | · | -13362.2% | -3604.7% | 59.6% | · | |
| EBITDA Margin | -581.4% | · | -14989.5% | -3662.3% | 59.7% | -643.0% | |
| ROA | -14.3% | · | -35.0% | -31.0% | 90.8% | -103.4% | |
| ROE | -18.7% | · | -55.4% | -39.5% | 65.2% | -151.1% | |
| ROIC | -32.5% | · | -67.5% | -42.0% | 68.4% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 9.0 | · | 9.6 | 18.8 | 12.9 | 3.4 | |
| Quick Ratio | 1.6 | · | 2.4 | 6.4 | 12.7 | 3.3 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.0 | 0.0 | 1.5 | 0.2 |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.00 | · | $1.24 | $1.88 | $2.55 | $0.66 | |
| Revenue / Share | · | · | $0.01 | $0.02 | $3.06 | · | |
| Cash Flow / Share | · | · | $-0.65 | $-0.78 | $1.74 | · | |
| Cash / Share | $0.10 | · | $0.38 | $0.64 | $2.67 | $1.10 | |
| EPS (TTM) | $-0.41 | $-0.41 | $-0.74 | $-0.77 | $1.76 | $-1.39 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 1181.3% | 44.4% | -73.9% | -99.3% | 1551.6% | · | |
| Revenue CAGR 3Y | 69.0% | -86.1% | -68.6% | · | · | · | |
| Revenue CAGR 5Y | -10.5% | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $7M | $566.0K | $392.0K | $2M | $208M | $13M | |
| Net Income TTM | $-17M | $-26M | $-52M | $-54M | $123M | $-81M | |
| Market Cap | $212M | · | $228M | $131M | $226M | $152M | |
| P/E | -4.0 | -2.3 | -4.4 | -2.4 | 1.8 | -1.7 | |
| P/S | 29.3 | · | 580.7 | 87.2 | 1.1 | 12.0 | |
| P/B | 1.6 | · | 2.6 | 1.0 | 1.3 | 3.5 | |
| P / Tangible Book | 1.6 | 1.0 | 2.6 | 1.0 | 1.3 | 3.5 | |
| P / Cash Flow | -5.5 | · | -5.0 | -2.4 | 1.9 | -2.9 | |
| P / FCF | -5.5 | · | -5.0 | -2.3 | 1.9 | -2.9 | |
| Earnings Yield | -25.1% | -43.9% | -23.0% | -41.4% | 54.8% | -60.2% |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $733.0K | $0 | $718.0K | $132.0K | $6M | $130.0K | $76.0K | $173.0K | $169.0K | $148.0K | $142.0K | $109.0K | $75.0K | $66.0K | $46.3K | $11.1K | |
| R&D Expense | $10M | $11M | $7M | $6M | $6M | $7M | $6M | $8M | $13M | $10M | $11M | $5M | $6M | $7M | $6M | $5M | |
| SG&A Expense | $6M | $7M | $6M | $7M | $5M | $6M | $5M | $6M | $8M | $7M | $8M | $7M | $8M | $8M | $7M | $8M | |
| Operating Expenses | $16M | $18M | $13M | $13M | $11M | $13M | $11M | $13M | $21M | $18M | $18M | $12M | $14M | $15M | $12M | $13M | |
| Operating Income | $-16M | $-18M | $-12M | $-13M | $-5M | $-13M | $-11M | $-13M | $-21M | $-17M | $-18M | $-12M | $-14M | $-15M | $-12M | $-13M | |
| Interest Income | $2M | $737.0K | $848.0K | $303.0K | $384.0K | $491.0K | $650.0K | $947.0K | $991.0K | $1M | · | · | · | · | · | · | |
| Other Non-op | $689.0K | $858.0K | $22M | $365.0K | $389.0K | $2M | $1M | $-780.0K | $29M | $6M | $3M | $776.0K | $2M | $2M | $618.1K | $836.1K | |
| Pretax Income | $-15M | $-17M | $10M | $-12M | $-5M | $-10M | $-9M | $-14M | $9M | $-12M | $-15M | $-11M | $-12M | $-13M | $-12M | $-12M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-50.0K | $0 | |
| Net Income | $-15M | $-17M | $10M | $-12M | $-5M | $-10M | $-9M | $-14M | $9M | $-12M | $-15M | $-11M | $-12M | $-13M | $-12M | $-12M | |
| EPS (Basic) | · | · | · | · | · | · | · | $-0.20 | $0.12 | $-0.17 | · | $-0.16 | $-0.18 | $-0.19 | $-0.16 | $-0.17 | |
| EPS (Diluted) | · | · | · | · | · | · | · | $-0.20 | $0.12 | $-0.17 | · | $-0.16 | $-0.18 | $-0.19 | $-0.16 | $-0.17 | |
| Shares (Basic) | · | · | · | · | · | · | · | 70,975,778 | 70,916,471 | 70,716,929 | · | 70,618,609 | 70,534,181 | 70,490,704 | · | 70,430,554 | |
| Shares (Diluted) | · | · | · | · | · | · | · | 70,975,778 | 71,200,798 | 70,716,929 | · | 70,618,609 | 70,534,181 | 70,490,704 | · | 70,430,554 | |
| EBITDA | $-16M | $-18M | · | $-13M | $-5M | $-12M | · | $-13M | $-21M | $-17M | · | $-12M | $-14M | $-15M | · | $-13M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $94M | $13M | $21M | $28M | $21M | $26M | $15M | $30M | $31M | $27M | $57M | $72M | $63M | $45M | $58M | |
| Prepaid Expense | $6M | $5M | $5M | $3M | $4M | $3M | $3M | $3M | $4M | $3M | $4M | $5M | $6M | $2M | $2M | $3M | |
| Current Assets | $124M | $160M | $74M | $29M | $42M | $46M | $56M | $66M | $81M | $93M | $110M | $92M | $102M | $120M | $131M | $140M | |
| PP&E (Net) | $201.0K | $217.0K | $252.0K | $269.0K | $285.0K | $346.0K | $433.0K | $509.0K | $618.0K | $686.0K | $769.0K | $856.5K | $955.6K | $1M | $1M | $1M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $899.5K | $795.1K | $689.8K | $581.4K | $449.8K | |
| Intangibles | $0 | $0 | $0 | $0 | $0 | $38.0K | $100.0K | $155.0K | $219.0K | $148.0K | $200.0K | $222.1K | $263.4K | $185.9K | $222.1K | $275.4K | |
| Other Non-current Assets | · | · | $0 | $0 | $0 | $39.0K | $92.0K | $182.0K | $246.0K | $174.0K | $210.0K | $248.7K | $290.0K | $212.5K | $261.2K | $275.4K | |
| Total Assets | $232M | $226M | $151M | $64M | $77M | $82M | $92M | $103M | $118M | $132M | $144M | $125M | $136M | $143M | $155M | $165M | |
| Accounts Payable | $4M | $9M | $2M | $2M | $4M | $2M | $3M | $3M | $5M | $4M | $4M | $1M | $4M | $2M | $2M | $1M | |
| Accrued Liabilities | $4M | $5M | $5M | $3M | $3M | $6M | $6M | $8M | $8M | $4M | $7M | $6M | $5M | $4M | $5M | $6M | |
| Current Liabilities | $10M | $16M | $8M | $7M | $9M | $9M | $11M | $12M | $14M | $9M | $11M | $9M | $10M | $7M | $7M | · | |
| Capital Leases | $11M | $12M | $12M | $12M | $13M | $13M | $13M | $14M | $14M | $14M | $15M | $15M | $15M | $16M | $16M | $16M | |
| Total Liabilities | $22M | $27M | $20M | $19M | $22M | $22M | $24M | $26M | $29M | $53M | $56M | $24M | $26M | $22M | $23M | $23M | |
| Common Stock | $185.0K | $167.0K | $130.0K | $71.0K | $71.0K | $71.0K | $71.0K | $71.0K | $71.0K | $71.0K | $71.0K | $70.7K | $70.6K | $70.5K | $70.5K | $70.5K | |
| Paid-in Capital | $564M | $537M | $452M | $376M | $375M | $374M | $372M | $371M | $370M | $368M | $366M | $364M | $362M | $360M | $358M | · | |
| Retained Earnings | $-354M | $-339M | $-322M | $-331M | $-319M | $-315M | $-304M | $-295M | $-281M | $-290M | $-278M | $-263M | $-251M | $-239M | $-226M | $-214M | |
| AOCI | $-750.0K | $-422.0K | $-202.0K | $-126.0K | $-69.0K | $-47.0K | $-35.0K | $36.0K | $-12.0K | $-19.0K | $1.0K | $-3.9K | $5.2K | $5.6K | $-42.2K | $-82.8K | |
| Stockholders' Equity | $210M | $198M | $131M | $45M | $56M | $59M | $68M | $76M | $89M | $78M | $88M | $101M | $111M | $121M | $132M | $142M | |
| Liabilities + Equity | $232M | $226M | $151M | $64M | $77M | $82M | $92M | $103M | $118M | $132M | $144M | $125M | $136M | $143M | $155M | $165M | |
| Shares Outstanding | 184,755,735 | 167,266,466 | 130,184,353 | 71,151,981 | 71,109,514 | 71,109,514 | 71,009,866 | 71,009,866 | 70,971,577 | 70,783,961 | 70,691,992 | 70,680,551 | 70,602,793 | 70,491,510 | 70,466,885 | 70,466,885 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $16.0K | $35.0K | $17.0K | $16.0K | $99.0K | $141.0K | $160.0K | $169.0K | $148.0K | $136.0K | $140.0K | $145.9K | $137.3K | $145.0K | $185.0K | $155.4K | |
| Stock-based Comp | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Amort. of Intangibles | $0 | $0 | $9.0K | $0 | $38.0K | $53.0K | $56.0K | $64.0K | $45.0K | $35.0K | $-9.0K | $41.0K | $32.0K | $36.0K | $75.8K | $53.3K | |
| Other Non-cash | · | $2M | · | · | · | $-1M | · | · | · | $-7M | · | · | · | $-817.2K | · | · | |
| Operating Cash Flow | $-18M | $-14M | $-10M | $-13M | $-5M | $-10M | $-10M | $-15M | $-14M | $-17M | $-12M | $-10M | $-12M | $-12M | $-9M | $-13M | |
| CapEx | · | · | $0 | $0 | $0 | $0 | $22.0K | $-4.0K | $34.0K | $19.0K | $13.0K | $5.6K | $7.4K | $14.0K | $119.9K | $18.6K | |
| Investing Cash Flow | $-87M | $6M | $-72M | $5M | $12M | $5M | $21M | $292.0K | $13M | $20M | $-49M | $-4M | $20M | $30M | $-4M | $-2M | |
| Stock Issued | $1.0K | $2M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $2M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $22M | $89M | $75M | $15.0K | $0 | $13.0K | $0 | $38.0K | $356.0K | $228.0K | $30M | $223.9K | $211.0K | $67.0K | $-43.6K | $81.6K | |
| Net Change in Cash | $-83M | $81M | · | · | $7M | $-5M | · | · | · | · | · | · | · | · | · | $-15M | |
| Free Cash Flow | · | · | · | · | · | $-10M | · | · | · | $-17M | · | · | · | $-12M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2141.6% | · | · | -9487.1% | -80.9% | -9653.9% | · | -7645.1% | -12140.2% | -11768.2% | · | -11038.5% | -18896.0% | -22509.5% | · | -115329.3% | |
| Net Margin | -2047.6% | · | · | -9210.6% | -74.7% | -7873.1% | · | -8096.0% | 5042.0% | -7901.3% | · | -10325.9% | -16544.4% | -20187.7% | · | -107798.3% | |
| Pretax Margin | -2047.6% | · | · | -9210.6% | -74.7% | -7873.1% | · | -8096.0% | 5042.0% | -7901.3% | · | -10325.9% | -16544.4% | -20187.7% | · | -107798.3% | |
| EBITDA Margin | -2141.6% | · | · | -9487.1% | -80.9% | -9545.4% | · | -7645.1% | -12140.2% | -11676.3% | · | -11038.5% | -18896.0% | -22290.9% | · | -115329.3% | |
| ROA | -9.7% | -11.1% | · | -14.6% | -4.8% | -9.6% | · | -12.3% | 6.7% | -8.5% | · | -7.8% | -7.9% | -8.0% | · | -6.4% | |
| ROE | -11.3% | -13.2% | · | -20.1% | -6.5% | -14.9% | · | -15.8% | 8.5% | -11.7% | · | -9.2% | -9.4% | -9.3% | · | -7.1% | |
| ROIC | -7.5% | -9.0% | · | -28.0% | -9.1% | -21.2% | · | -17.3% | -23.1% | -22.2% | · | -11.9% | -12.8% | -12.3% | · | -9.0% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.4 | 10.2 | · | 4.2 | 4.7 | 4.9 | · | 5.7 | 5.7 | 10.5 | · | 10.6 | 10.1 | 17.8 | · | · | |
| Quick Ratio | 1.1 | 6.0 | · | 3.0 | 3.2 | 2.3 | · | 1.3 | 2.1 | 3.5 | · | 6.6 | 7.1 | 9.4 | · | · |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.14 | $1.19 | · | $0.63 | $0.78 | $0.83 | · | $1.07 | $1.25 | $1.11 | · | $1.43 | $1.57 | $1.72 | · | $2.02 | |
| Revenue / Share | · | · | · | · | · | · | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | |
| Cash Flow / Share | · | · | · | · | · | · | · | · | · | $-0.24 | · | · | · | $-0.17 | · | · | |
| Cash / Share | $0.06 | $0.56 | · | $0.29 | $0.40 | $0.30 | · | $0.21 | $0.42 | $0.43 | · | $0.81 | $1.01 | $0.89 | · | $0.83 | |
| EPS (TTM) | · | · | · | · | · | · | · | · | · | · | · | $-0.69 | $-0.70 | $-0.73 | · | $-0.98 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $7M | · | $7M | $7M | $548.0K | · | $632.0K | $568.0K | $474.0K | · | $296.3K | $198.4K | $123.4K | · | $1M | |
| Net Income TTM | $-34M | $-24M | · | $-36M | $-38M | $-25M | · | $-33M | $-30M | $-51M | · | $-49M | $-49M | $-51M | · | $-69M | |
| Market Cap | $497M | $371M | · | $92M | $23M | $22M | · | $84M | $55M | $216M | · | $271M | $232M | $182M | · | $130M | |
| P/E | · | · | · | · | · | · | · | · | · | · | · | -5.6 | -4.7 | -3.5 | · | -1.9 | |
| P/S | 314.0 | 52.1 | · | 14.0 | 3.5 | 40.5 | · | 132.6 | 96.1 | 455.5 | · | 916.1 | 1167.3 | 1474.0 | · | 89.0 | |
| P/B | 2.4 | 1.9 | · | 2.1 | 0.4 | 0.4 | · | 1.1 | 0.6 | 2.8 | · | 2.7 | 2.1 | 1.5 | · | 0.9 | |
| P / Tangible Book | 2.4 | 1.9 | · | 2.1 | 0.4 | 0.4 | · | 1.1 | 0.6 | 2.8 | · | 2.7 | 2.1 | 1.5 | · | 0.9 | |
| P / Cash Flow | · | -26.7 | · | · | · | -2.2 | · | · | · | -12.9 | · | · | · | -15.0 | · | · | |
| Earnings Yield | · | · | · | · | · | · | · | · | · | · | · | -18.0% | -21.3% | -28.3% | · | -53.3% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $7M | $566.0K | $392.0K | $2M | $208M |
| Margen Operativo % | -585.2% | · | -15134.6% | -3696.4% | 59.6% |
| Beneficio neto | $-17M | $-26M | $-52M | $-54M | $123M |
| EPS Diluido | · | · | $-0.74 | $-0.77 | $1.76 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 9.0 | · | 9.6 | 18.8 | 12.9 |
| Ratio Rápido | 1.6 | · | 2.4 | 6.4 | 12.7 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-38M | · | $-46M | $-56M | $118M |
Propietarios institucionales (13F) 142 declarantes · $378.9M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
142
Valor en tenencia
$378.9M
Nuevas posiciones
46
Posiciones cerradas
17
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 46 (+15 vs trimestre anterior) | 17 (+9 vs trimestre anterior) | 34 (-1 vs trimestre anterior) | 29 (+8 vs trimestre anterior) | +21.2M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| EVENTIDE ASSET MANAGEMENT, LLC | $31 774 928 | 11 812 241 | 8,39% | Acciones |
| BlackRock, Inc. | $29 115 162 | 10 823 480 | 7,68% | Acciones |
| RA CAPITAL MANAGEMENT, L.P. | $28 247 604 | 10 500 968 | 7,45% | Acciones |
| Affinity Asset Advisors, LLC | $27 288 872 | 10 144 562 | 7,20% | Acciones |
| JANUS HENDERSON GROUP PLC | $23 731 510 | 10 714 000 | 6,26% | Acciones |
| STATE STREET CORP | $21 253 058 | 7 900 765 | 5,61% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $20 874 707 | 7 760 114 | 5,51% | Acciones |
| ADAR1 Capital Management, LLC | $19 953 019 | 7 417 479 | 5,27% | Acciones |
| Balyasny Asset Management L.P. | $18 074 314 | 6 719 076 | 4,77% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $16 580 571 | 6 163 781 | 4,38% | Acciones |
| FEDERATED HERMES, INC. | $16 009 982 | 5 951 666 | 4,23% | Acciones |
| BRAIDWELL LP | $15 923 358 | 5 919 464 | 4,20% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $10 957 549 | 4 072 653 | 2,89% | Acciones |
| TAKEDA PHARMACEUTICAL CO LTD | $9 791 595 | 7 531 996 | 2,58% | Acciones |
| SILVERARC CAPITAL MANAGEMENT, LLC | $8 342 037 | 3 101 129 | 2,20% | Acciones |
| STEMPOINT CAPITAL LP | $6 502 491 | 2 417 283 | 1,72% | Acciones |
| Ikarian Capital, LLC | $6 105 503 | 2 269 704 | 1,61% | Acciones |
| Point72 Asset Management, L.P. | $5 234 006 | 1 945 727 | 1,38% | Acciones |
| VANGUARD GROUP INC | $5 007 730 | 3 072 227 | 1,32% | Acciones |
| SPHERA FUNDS MANAGEMENT LTD. | $3 639 570 | 1 353 000 | 0,96% | Acciones |
| NORTHERN TRUST CORP | $3 352 114 | 1 246 139 | 0,88% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $3 068 626 | 1 140 753 | 0,81% | Acciones |
| Propel Bio Management, LLC | $3 000 797 | 1 115 538 | 0,79% | Acciones |
| Rosalind Advisors, Inc. | $2 980 504 | 1 107 994 | 0,79% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 773 237 | 1 030 943 | 0,73% | Acciones |
| Sio Capital Management, LLC | $2 704 348 | 1 005 334 | 0,71% | Acciones |
| Ensign Peak Advisors, Inc | $2 657 946 | 988 084 | 0,70% | Acciones |
| Nuveen, LLC | $2 402 853 | 893 254 | 0,63% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $2 239 097 | 832 378 | 0,59% | Acciones |
| WELLS FARGO & COMPANY/MN | $2 222 494 | 826 206 | 0,59% | Acciones |
| ORBIMED ADVISORS LLC | $2 009 430 | 747 000 | 0,53% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $1 984 569 | 737 758 | 0,52% | Acciones |
| Saturn V Capital Management LP | $1 783 631 | 663 060 | 0,47% | Acciones |
| Ally Bridge Group (NY) LLC | $1 680 069 | 624 561 | 0,44% | Acciones |
| UBS Group AG | $1 234 487 | 458 917 | 0,33% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1 194 473 | 444 042 | 0,32% | Acciones |
| Bank of New York Mellon Corp | $1 119 897 | 416 318 | 0,30% | Acciones |
| BANK OF AMERICA CORP /DE/ | $1 101 528 | 409 490 | 0,29% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $1 043 445 | 387 767 | 0,28% | Acciones |
| GOLDMAN SACHS GROUP INC | $894 942 | 332 692 | 0,24% | Acciones |
| Informed Momentum Co LLC | $698 407 | 259 631 | 0,18% | Acciones |
| Atom Investors LP | $677 439 | 251 836 | 0,18% | Acciones |
| CIBC WORLD MARKET INC. | $588 709 | 218 851 | 0,16% | Acciones |
| Parkman Healthcare Partners LLC | $532 477 | 197 947 | 0,14% | Acciones |
| SEI INVESTMENTS CO | $529 083 | 196 685 | 0,14% | Acciones |
| CITIGROUP INC | $513 946 | 191 058 | 0,14% | Acciones |
| Invesco Ltd. | $470 481 | 174 900 | 0,12% | Acciones |
| RHUMBLINE ADVISERS | $457 666 | 170 139 | 0,12% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $455 638 | 169 382 | 0,12% | Acciones |
| DEUTSCHE BANK AG\ | $401 862 | 149 391 | 0,11% | Acciones |
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Mark Feldberg, TLS Advisors LLC, Shira Capital LLC, TradeLink Securities LLC, Tripletail Capital Management LP ×5 presentaciones | 27 de mayo de 2020 | · | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 20 insiders · 9 directivos · 8 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Margaret A. Alexander | President and CEO | 26 de febrero de 2026 A | 61 750 | 0 | 1 | $-16 901 |
| Charles Ross Carter | Chief Financial Officer | 6 de julio de 2026 A | 94 375 | 0 | 0 | $0 |
| Yaron Werber | CBO, CFO, Sec. and Treas. | 19 de enero de 2018 A | · | 0 | 0 | $0 |
| Amit Rakhit | President and CMO | 14 de julio de 2021 M | 726 823 | 0 | 0 | $0 |
| Jason Tardio | Chief Operating Officer | 22 de febrero de 2024 A | 28 125 | 0 | 0 | $0 |
| Thomas Michael Perone | General Counsel, Secretary | 22 de febrero de 2024 A | 28 125 | 0 | 0 | $0 |
| Dirk Haasner | SVP, Global Regulatory Affairs | 17 de diciembre de 2020 A | · | 0 | 0 | $0 |
| Timothy Daly | EVP,Finance & Corp. Controller | 17 de diciembre de 2020 A | · | 0 | 0 | $0 |
| Ana Ward | SVP and General Counsel | 24 de febrero de 2019 A | · | 0 | 0 | $0 |
| Anna Greka | Consejero | 15 de junio de 2026 A | · | 0 | 0 | $0 |
| Kevin Joseph Fitzgerald | Consejero | 7 de abril de 2026 A | 17 578 | 0 | 0 | $0 |
| Stelios Papadopoulos | Consejero | 7 de abril de 2026 A | 217 578 | 0 | 0 | $0 |
| Karen Bernstein | Consejero | 26 de febrero de 2026 A | 20 000 | 0 | 0 | $0 |
| Robert Michael Poole | Consejero | 22 de febrero de 2024 A | · | 0 | 0 | $0 |
| Douglas E Williams | Consejero | 17 de mayo de 2021 A | 5 000 | 0 | 0 | $0 |
| Matthew During | Consejero | 1 de abril de 2019 A | 4 307 314 | 0 | 0 | $0 |
| Bart Friedman | · | 7 de abril de 2026 A | 8 789 | 0 | 0 | $0 |
| Jeremy M Levin | · | 23 de marzo de 2026 M | 3 735 048 | 0 | 0 | $0 |
| Barbara Gayle Duncan | · | 26 de febrero de 2026 A | · | 0 | 0 | $0 |
| Jeffrey A Rona | · | 26 de febrero de 2026 A | 156 313 | 0 | 1 | $-12 384 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 17 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IBRN · iShares Trust | 0,46% | 13 036 SH | 11 de septiembre de 2026 | Diario |
| IWC · iShares Trust | 0,09% | 516 966 SH | 11 de septiembre de 2026 | Diario |
| LABU · Direxion Shares ETF Trust | 0,08% | 167 199 NS | 31 de julio de 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,02% | 2 284 NS | 31 de julio de 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 117 475 SH | 19 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,01% | 3 906 782 SH | 11 de septiembre de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 140 650 SH | 1 de octubre de 2026 | Diario |
| RSSL · Global X Funds | 0,01% | 72 842 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1 952 040 SH | 19 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 881 326 SH | 19 de agosto de 2026 | Diario |
| IWO · iShares Trust | 0,00% | 169 022 SH | 11 de septiembre de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,00% | 83 973 NS | 31 de julio de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 342 580 SH | 11 de septiembre de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 5 653 216 SH | 19 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 19 401 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 12 741 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 1 268 401 SH | 11 de septiembre de 2026 | Diario |
OVID Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 16 analistas
COMPRA
Objetivo mediano
$5.00
+110,1%
7 43,8%
Compra fuerte
8 50,0%
Compra
1 6,2%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
9 analistas · 2026-10-01Objetivo medio $5.92 +148,6%
← Por Debajo de Todos los Objetivos
Precio Actual $2.38
Mín$4.00
Media$5.92
Máx$9.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | · |
| MNPR | · | · | · | · | · | · |
| CAPR | $1.66B | -12.8 | -11.6% | · | -51.1% | · |
| NGNE | $319M | -4.9 | · | · | -33.6% | · |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | · |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | · |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | · |
| TECX | $391M | -5.2 | · | · | -27.7% | · |
| DMAC | $428M | · | · | · | -78.7% | · |
| MYGN | $575M | -1.6 | -1.6% | -44.4% | -96.8% | 69.9% |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 13, 2026